Chilblain and Acral Purpuric Lesions in COVID-19

Wiwanitkit, V.

doi:10.1016/j.adengl.2020.06.002

Actas Dermo-Sifiliográficas

ISSN: 0001-7310

The Official publication of the Spanish Academy of Dermatology and Venereology (AEDV). Actas Dermo-Sifiliográficas, founded in 1909, is the oldest monthly medical journals published in Spain. In the year 2006 has been indexed in the Medlinedatabase, and has become a vehicle for expressing the most current Spanish medicine and modern. All articles are subjected to a rigorous process of revision in pairs, and careful editing for literary and scientific style. Together with the classic Original and Clinical Case Study sections, we also include Reviews, Case Diagnoses, and Book Reviews. Dermo-Sifiliográficas is an essential publication for anyone who needs to be current on all aspects of Spanish and world dermatology.

Con su JCI 2023, Actas Dermo-Sifiliográficas es Q1 y se posiciona la revista nº 15 de 94 en Dermatología

With JCI 2023, Actas Dermo-Sifiliográficas is Q1 and is ranked number 15 of 94 in Dermatology

Indexed in:

Web of Science, Emerging Sources Citation Index (WoS, Clarivate), PubMed/Medlinee, IME, Embase/Excerpta Medica, Embase, Toxline, Cab Abstracts, Cab Health, Cancerlit NIm, Serline: Biomed, Bibliomed, Pascal, Scopus , IBECS

I would like to share ideas on the report on “Lesiones pernióticas y acrales en España durante el confinamiento por COVID: análisis retrospectivo de 12 casos” with a great interest.1 El Romaní et al. noted that Como conclusión, este sorprendente cuadro clínico es atípico porque ha aparecido durante el clima cálido, no asociado con la perniosis común y, aunque tiene una relación temporal con la pandemia de COVID, en ninguno de los pacientes hay evidencia demostrable de infección por COVID-19 actual o pasada.1 “Regarding the present report by Romaní et al.,1 it should performed additional study to rule out other possible causes of skin lesion such as other concurrent virus infection. In fact, Chilblain and Acral Purpuric Lesions are new emerging dermatological conditions that are reported from many countries although there is a lack of report from tropical zone.2,3 The new evidences show that there might be an association with COVID-19. The identification of immunoglobulin to SARSCoV2 in some patients becomes the clue for further study on dermatopathophysiology of chilblain and acral purpuric lesions in COVID-19.4

References

[1]

J. Romaní, E. Baselga, O. Mitjà, N. Riera-Martí, P. Garbayo, A. Vicente, et al.

Chilblain and acral purpuric lesions in spain during COVID confinement: retrospective analysis of 12 cases.

Actas Dermosifiliogr, (2020),

http://dx.doi.org/10.1016/j.ad.2020.04.002

[2]

E.E. Freeman, D.E. McMahon, J.B. Lipoff, M. Rosenbach, C. Kovarik, J. Takeshita, et al.

The American Academy of Dermatology COVID-19 Registry: crowdsourcing dermatology in the age of COVID-19.

J Am Acad Dermatol, (2020),

[3]

B. Joob, V. Wiwanitkit.

Chilblains-like Lesions and COVID-19.

Pediatr Dermatol, (2020),

http://dx.doi.org/10.1111/pde.14238

[4]

M. El Hachem, A. Diociaiuti, C. Concato, R. Carsetti, C. Carnevale, M. Ciofi Degli Atti, et al.

A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.

J Eur Acad Dermatol Venereol, (2020),

http://dx.doi.org/10.1111/jdv.16682

☆

Please cite this article as: Wiwanitkit V. Chilblain y lesiones purpúricas acrales en COVID-19. Actas Dermosifiliogr. 2020;111:627.